The infusion positions Sovato to scale the nascent telesurgery market, potentially expanding access to advanced surgical care while attracting further industry partnerships and validation. It underscores growing investor confidence in remote‑surgery technology as a transformative health‑care solution.
Comments
Want to join the conversation?
Loading comments...